CIC
MGNX icon

Cornercap Investment Counsel’s MacroGenics MGNX Stock Holding History

Cornercap Investment Counsel’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,025
Closed -$68.1K – 605
2024
Q2 		$68.1K Sell
16,025
-192
-1% -$1.87K 0.01% 577
2024
Q1 		$239K Sell
16,217
-12,893
-44% -$195K 0.04% 546
2023
Q4 		$280K Sell
29,110
-6,233
-18% -$43.1K 0.05% 489
2023
Q3 		$165K Sell
35,343
-390
-1% -$1.94K 0.03% 503
2023
Q2 		$191K Sell
35,733
-15,748
-31% -$97.1K 0.03% 519
2023
Q1 		$369K Sell
51,481
-225
-0.4% -$1.35K 0.07% 454
2022
Q4 		$347K Sell
51,706
-4,231
-8% -$23.2K 0.06% 461
2022
Q3 		$194K Buy
55,937
+29,223
+109% +$112K 0.04% 499
2022
Q2 		$79K Buy
+26,714
New +$140K 0.01% 533

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cornercap Investment Counsel's MGNX Position: Q3 2024 in Review

Cornercap Investment Counsel sold out of MacroGenics (MGNX) in Q3 2024, closing a stake of 16,025 shares — an estimated $68.1K sold.

Cornercap Investment Counsel first reported a position in MGNX in Q2 2022 and held it in 9 quarters. The position peaked at $369K in Q1 2023. 124 funds tracked by Wall St. Rank hold MGNX as of Q3 2024.

  • Cornercap Investment Counsel reported no remaining MacroGenics position as of Q3 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 16,025 MacroGenics shares in Q3 2024, an estimated $68.1K.
  • Cornercap Investment Counsel first reported a position in MacroGenics in Q2 2022 and held it in 9 quarters.
  • Cornercap Investment Counsel's MacroGenics position peaked at $369K in Q1 2023.
  • 124 funds tracked by Wall St. Rank held MacroGenics as of Q3 2024.

Based on Cornercap Investment Counsel's 13F filing for Q3 2024, filed 6 Nov 2024.